COVID-19 HASTALARINDA BİYOKİMYASAL, İNFLAMATUAR VE HEMATOLOJİK PARAMETRELERİN DEĞERLENDİRİLMESİ: COVID-19 HASTALARINDA BİYOKİMYASAL, İNFLAMATUAR VE HEMATOLOJİK PARAMETRELERİN DEĞERLENDİRİLMESİ

ayşe Umay Çalışır; Birsen Aydın; Şirin Çetin; meryem Çetin

doi:10.5281/zenodo.14032663

Yazarlar

ayşe Umay Çalışır Amasya Üniversitesi
Birsen Aydın Amasya Üniversitesi
Şirin Çetin
meryem Çetin Amasya Üniversitesi

DOI:

https://doi.org/10.5281/zenodo.14032663

Anahtar Kelimeler:

COVID-19- yaş- cinsiyet- laboratuvar parametreleri

Özet

Çalışmanın amacı: Bu çalışma, COVİD-19 hastalarında yaş ve cinsiyet gibi demografik gözlem rutin, laboratuvar ortamındaki değerlendirmeleri gerçekleştirmeyi hedefliyor. COVİD-19 hastalığı, hafiften kritik kartlı organ bakımına kadar geniş bir yelpazede klinik bulgular sergilenebilir. Bu biyolojik, biyokimyasal belirteçlerin bireysel prognozunu tahmin etmedeki rolü oldukça önemlidir.

Yöntemler: Çalışmada, COVİD-19 hastalarında yaş ve cinsiyete bağlı olarak kalp, ve kalp fonksiyonlarını değerlendiren biyokimyasal ilaç ile belirleneçleri analiz edilmiştir. Tam kan sayımı (CBC), C-reaktif protein (CRP), D-Dimer, fibrinojen, ALT, AST ve LDH gibi etkiler takip edilmiştir.

Bulgular: Çalışmada yaşlı COVİD-19 hastalarında, özellikle hız enzimleri (AST, ALT), LDH, CRP ve D-Dimer seviyelerinde anlamlı şekilde gözlemlenmiştir. Bu durum, yaşlı bireylerin daha şiddetli inflamatuar yanıtlar ve organ hasarına daha dayanıklı olduğunu göstermektedir. Ayrıca trombositopeni ve hiperkoagülasyon gibi trombozla birlikte belirtileçlerde de yaşla birlikte artış görüldü.

Sonuç: Çalışmamız, COVID-19 hastalarında yaşla birlikte inflamatuar özellikler ve organ fonksiyonlarındaki bozulmaların belirgin hale geldiğini göstermektedir. Yaşlı hastaların ayrılması gereken ve bu gruplara ayrılan prognozunu dikkate almak için CRP, D-Dimer ve LDH gibi biyokimyasal belirteçlerin toplanıp faydalı hale getirilmesi için varılmıştır.

Anahtar Kelimler: COVİD-19, yaş, cinsiyet, laboratuvar çalışanları

İndirmeler

İndirme verileri henüz mevcut değil.

Referanslar

World Health Organization (2020). Coronavirus disease (COVID-19) pandemic.

Turkish Ministry of Health (2022). COVID-19 statistics in Turkey.

Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N. H., Nitsche, A., Müller, M. A., Drosten, C., and Pöhlmann, S. (2020). SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell, 181(2), 271–280.e8.Richardson S. et al. (2020). Presenting Characteristics Comorbidities and Outcomes Among 5700 Patients Hospitalized with COVID-19. JAMA.

Varga, Z., Flammer, A. J., Steiger, P., Haberecker, M., Andermatt, R., Zinkernagel, A. S., Mehra, M. R., Schuepbach, R. A., Ruschitzka, F., & Moch, H. (2020). Endothelial cell infection and endotheliitis in COVID-19. Lancet (London, England), 395(10234), 1417–1418. https://doi.org/10.1016/S0140-6736(20)30937-5

Gupta, A., Madhavan, M. V., Sehgal, K., Nair, N., Mahajan, S., Sehrawat, T. S., Bikdeli, B., Ahluwalia, N., Ausiello, J. C., Wan, E. Y., Freedberg, D. E., Kirtane, A. J., Parikh, S. A., Maurer, M. S., Nordvig, A. S., Accili, D., Bathon, J. M., Mohan, S., Bauer, K. A., Leon, M. B., … Landry, D. W. (2020). Extrapulmonary manifestations of COVID-19. Nature medicine, 26(7), 1017–1032. https://doi.org/10.1038/s41591-020-0968-3

Borobia A. M. et al. (2020). High mortality in COVID-19 older patients. Revista Española de Salud Pública.

Jones, P. (2019). The impact of environmental pollution on child health. Journal of Environmental Science.

Smith J. (2021). Teacher education and environmental health: Enhancing awareness through targeted programs. International Journal of Education and Development.

Hoffmann M. et al. (2020). SARS-CoV-2 cell entry depends on ACE2. Cell.

Gupta A. et al. (2020). Extrapulmonary manifestations of COVID-19. Nature Medicine.

Wu Z, Mcgoogan JM. (2020). Characteristics of and İmportant Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak İn China: Summary of a Report of 72314 Cases From The Chinese Center For Disease Controland Prevention. JAMA.323, 1239–1242.

Moledina, S. M., Maini, A. A., Gargan, A., Harland, W., Jenney, H., Phillips, G., Thomas, K., Chauhan, D., and Fertleman, M. (2020). Clinical Characteristics and Predictors of Mortality in Patients with COVID-19 Infection Outside Intensive Care. International Journal Of General Medicine, 13, 1157–1165.

Berenguer, J., Ryan, P., Rodríguez-Baño, J., Jarrín, I., Carratalà, J., Pachón, J., Yllescas, M., Arriba, J. R. (2020). Characteristics And Predictors Of Death Among 4035 Consecutively Hospitalized Patients With COVID-19 İn Spain. Clinical microbiology and infection : The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases, 26(11), 1525–1536.

Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., Niu, P., Zhan, F., Ma, X., Wang, D., Xu, W., Wu, G., Gao, G. F., Tan, W., and China Novel Coronavirus Investigating and Research Team (2020). A Novel Coronavirus from Patients with Pneumonia in China, 2019. The New England Journal of Medicine, 382(8), 727–733.

Rees, E. M., Nightingale, E. S., Jafari, Y., Waterlow, N. R., Clifford, S., B Pearson, C. A., Group, C. W., Jombart, T., Procter, S. R., and Knight, G. M. (2020). COVID-19 Length Of Hospital Stay: A Systematic Review and Data Synthesis. BMC Medicine, 18(1), 270.

Liu, X., Zhou, H., Zhou, Y., Wu, X., Zhao, Y., Lu, Y., Tan, W., Yuan, M., Ding, X., Zou, J., Li, R., Liu, H., Ewing, R. M., Hu, Y., Nie, H., and Wang, Y. (2020). Risk Factors Associated With Disease Severity And Length Of Hospital Stay in COVID-19 Patients. The Journal Of Infection, 81(1), E95–E97.

Pourbagheri-Sigaroodi, A., Bashash, D., Fateh, F., and Abolghasemi, H. (2020). Laboratory findings in COVID-19 diagnosis and prognosis. Clinica Chimica Acta, 510, 475-482.

Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., Cheng, Z., Yu, T., Xia, J., Wei, Y., Wu, W., Xie, X., Yin, W., Li, H., Liu, M., Xiao, Y., Gao, H., Guo, L., Xie, J., Wang, G., Jiang, R., Gao, Z., Jin, Q., Wang, J., Cao, B. (2020). Clinical Features of Patients İnfected with 2019 Novel Coronavirus in Wuhan, China. Lancet (London, England), 395(10223), 497–506.

İnternet:URL:https://www.yuksekihtisasuniversitesi.edu.tr/uploads/docs/corona/1586249787_covId-kanhucreleri.pdf. Son Erişim Tarihi: 29.10.2022.

Rej R. (1978). Aspartate Aminotransferase Activity and İsoenzyme Proportions in Human Liver Tissues. Clinical Chemistry, 24(11), 1971–1979.

Garrido, I., Liberal, R., & Macedo, G. (2020). Review Article: COVID-19 and Liver Disease-What We Know on 1st May 2020. Alimentary Pharmacology & Therapeutics, 52(2), 267–275.

Mantovani, A., Beatrice, G., & Dalbeni, A. (2020). Coronavirus Disease 2019 and Prevalence of Chronic Liver Disease: A Meta-Analysis. Liver İnternational: Official Journal of the International Association for the Study of the Liver, 40(6), 1316–1320.

Hu, C., Li, J., Xing, X., Gao, J., Zhao, S.,and Xing, L. (2021). The Effect of Age on The Clinical and Immune Characteristics of Critically Ill Patients with COVID-19: A Preliminary Report. Plos One, 16(3), e0248675.

An, X. S., Li, X. Y., Shang, F. T., Yang, S. F., Zhao, J. Y., Yang, X. Z., & Wang, H. G. (2020). Clinical Characteristics and Blood Test Results in COVID-19 Patients. Annals of Clinical and Laboratory Science, 50(3), 299–307.

Bi, X., Su, Z., Yan, H., Du, J., Wang, J., Chen, L., Peng, M., Chen, S., Shen, B., & Li, J. (2020). Prediction of Severe Illness Due to COVID-19 Based on an Analysis of Initial Fibrinogen to Albumin Ratio and Platelet Count. Platelets, 31(5), 674–679.

Thachil J. (2020). The protective rather than prothrombotic fibrinogen in COVID-19 and other inflammatory states. Journal of Thrombosis and Haemostasis, 18(8), 1849–1852.

Neumann-Podczaska, A., Al-Saad, S. R., Karbowski, L. M., Chojnicki, M., Tobis, S., and Wieczorowska-Tobis, K. (2020). COVID 19 - Clinical Picture in the Elderly Population: A Qualitative Systematic Review. Aging and disease, 11(4), 988–1008.

Song, J., Hu, W., Yu, Y., Shen, X., Wang, Y., Yan, J., Yang, X., Gong, S., & Wang, M. (2020). A Comparison of Clinical Characteristics and Outcomes in Elderly and Younger Patients with COVID-19. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research, 26, e925047.

Gómez-Belda, A. B., Fernández-Garcés, M., Mateo-Sanchis, E., Madrazo, M., Carmona, M., Piles-Roger, L., and Artero, A. (2021). COVID-19 in Older Adults: What are the Differences with Younger Patients?. Geriatrics and Gerontology International, 21(1), 60–65.

Dadras, O., SeyedAlinaghi, S., Karimi, A., Shamsabadi, A., Qaderi, K., Ramezani, M., Mirghaderi, S. P., Mahdiabadi, S., Vahedi, F., Saeidi, S., Shojaei, A., Mehrtak, M., Azar, S. A., Mehraeen, E., and Voltarelli, F. A. (2022). COVID-19 Mortality and İts Predictors in The Elderly: A Systematic Review. Health Science Reports, 5(3), e657.

Fanelli, V., Fiorentino, M., Cantaluppi, V., Gesualdo, L., Stallone, G., Ronco, C., and Castellano, G. (2020). Acute Kidney Injury in SARS-CoV-2 Infected Patients. Critical Care, 24(1), 155.

Mari, D., Coppola, R., & Provenzano, R. (2008). Hemostasis Factors and Aging. Experimental Gerontology, 43(2), 66–73.

Slaats, J., Ten Oever, J., van de Veerdonk, F. L., and Netea, M. G. (2016). IL-1β/IL-6/CRP and IL-18/ferritin: Distinct Inflammatory Programs in Infections. PLoS pathogens, 12(12), e1005973.

Haybar, H., Pezeshki, S., and Saki, N. (2019). Evaluation of Complete Blood Count Parameters in Cardiovascular Diseases: an Early İndicator of Prognosis?. Experimental and Molecular Pathology, 110, 104267.

Du, R. H., Liang, L. R., Yang, C. Q., Wang, W., Cao, T. Z., Li, M., Guo, G. Y., Du, J., Zheng, C. L., Zhu, Q., Hu, M., Li, X. Y., Peng, P., and Shi, H. Z. (2020). Predictors of Mortality for Patients with COVID-19 Pneumonia Caused by SARS-Cov-2: A Prospective Cohort Study. The European Respiratory Journal, 55(5), 2000524.

COVID-19 HASTALARINDA BİYOKİMYASAL, İNFLAMATUAR VE HEMATOLOJİK PARAMETRELERİN DEĞERLENDİRİLMESİ